Tweet
The Centre on Friday said that Covaxin's third phase trial data will be released by June 20. This comes after the US Food and Drug Administration decided not to give Emergency Use Authorisation (EUA) to Covaxin and "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) with additional data, nixinghopes of EUA.